MTP - マイダテック・ファ―マ (Midatech Pharma PLC) マイダテック・ファ―マ

 MTPのチャート


 MTPの企業情報

symbol MTP
会社名 Midatech Pharma PLC (マイダテック・ファ―マ)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Midatech Pharma PLC is an early-stage biopharmaceutical company that focuses on commercializing and developing products in oncology and other therapeutic areas. The Company''s segments include Pipeline Research and Development and Commercial. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms. The Commercial segment distributes and sells the commercial products. Its products include Zuplenz Gelclair Oravig and Soltamox. Zuplenz is an oral soluble film indicated for moderately emetogenic chemotherapy-induced nausea and vomiting (CINV) radiotherapy-induced nausea and vomiting (RINV) and post-operative nausea and vomiting (PONV). Gelclair is a product indicated for the management and relief of pain due to oral mucositis. Oravig is an orally dissolving buccal tablet approved for oral thrush. Soltamox is an oral liquid solution of tamoxifen citrate for the prevention of breast cancer.   マイダテック・ファ―マはイギリスの医療系持株会社。子会社を通じ、ナノ化薬物の持続放出技術を用いた治療薬の開発と商業化に従事。主に糖尿病、肝臓がん、卵巣がん、悪性脳腫瘍、及び神経系や眼系の病気に対する治療において、適切なタイミングで、適切な患部に薬物を送達したり、既存薬の持続放出を可能にさせる。本社はアビングドン。   
本社所在地 65 Innovation Drive Milton Park Abingdon Oxfordshire OX14 4RQ GBR
代表者氏名
代表者役職名
電話番号
設立年月日 41883
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 85人
url www.midatechpharma.com
nasdaq_url https://www.nasdaq.com/symbol/mtp
adr_tso 2920413
EBITDA EBITDA ー
終値(lastsale) 0.58
時価総額(marketcap) 1693839.54
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 MTPのテクニカル分析


 MTPのニュース

   Midatech Pharma PLC - Parliament Highlights Need for New DIPG Treatments - Vox Markets  2020/12/09 07:00:00 VOX Markets
UK Parliament Debate Highlights the Need for New DIPG Treatments. Midatech Pharma PLC, an R&D biotechnology company focused on improving the biodelivery and biodistribution of medicines, is pleased to note that its research effort to find novel treatments for Diffuse Intrinsic Pontine Glioma was recognised during a debate at Westminster Hall in the UK…
   Midatech Pharma (NASDAQ:MTP) versus Inflarx (NASDAQ:IFRX) Head-To-Head Contrast  2020/10/24 04:00:46 Dispatch Tribunal
Midatech Pharma (NASDAQ:MTP) and Inflarx (NASDAQ:IFRX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Valuation and Earnings This table compares Midatech Pharma and Inflarx’s revenue, earnings per share (EPS) and […]
   Midatech Pharma (NASDAQ:MTP) Shares Gap Down to $2.36  2020/10/22 11:25:00 Dakota Financial News
Shares of Midatech Pharma plc (NASDAQ:MTP) gapped down before the market opened on Tuesday . The stock had previously closed at $2.36, but opened at $2.16. Midatech Pharma shares last traded at $2.19, with a volume of 6,805 shares. The business has a 50-day simple moving average of $1.91 and a 200-day simple moving average […]
   Midatech Pharma (NASDAQ:MTP) Shares Gap Up to $2.00  2020/10/21 01:18:51 Daily Political
Midatech Pharma plc (NASDAQ:MTP) gapped up before the market opened on Monday . The stock had previously closed at $2.00, but opened at $2.78. Midatech Pharma shares last traded at $2.60, with a volume of 199,218 shares. The stock has a 50 day moving average price of $1.92 and a 200 day moving average price […]
   MOVERS OF MONDAY 19 OCTOBER 2020 - Vox Markets  2020/10/19 15:53:35 VOX Markets
See Today's Market Movers Featuring Cineworld, Bezant Resources, Remote Monitored Systems, Midatech Pharma and FirstGroup
   Midatech Pharma PLC - Parliament Highlights Need for New DIPG Treatments - Vox Markets  2020/12/09 07:00:00 VOX Markets
UK Parliament Debate Highlights the Need for New DIPG Treatments. Midatech Pharma PLC, an R&D biotechnology company focused on improving the biodelivery and biodistribution of medicines, is pleased to note that its research effort to find novel treatments for Diffuse Intrinsic Pontine Glioma was recognised during a debate at Westminster Hall in the UK…
   Midatech Pharma (NASDAQ:MTP) versus Inflarx (NASDAQ:IFRX) Head-To-Head Contrast  2020/10/24 04:00:46 Dispatch Tribunal
Midatech Pharma (NASDAQ:MTP) and Inflarx (NASDAQ:IFRX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk. Valuation and Earnings This table compares Midatech Pharma and Inflarx’s revenue, earnings per share (EPS) and […]
   Midatech Pharma (NASDAQ:MTP) Shares Gap Down to $2.36  2020/10/22 11:25:00 Dakota Financial News
Shares of Midatech Pharma plc (NASDAQ:MTP) gapped down before the market opened on Tuesday . The stock had previously closed at $2.36, but opened at $2.16. Midatech Pharma shares last traded at $2.19, with a volume of 6,805 shares. The business has a 50-day simple moving average of $1.91 and a 200-day simple moving average […]
   Midatech Pharma (NASDAQ:MTP) Shares Gap Up to $2.00  2020/10/21 01:18:51 Daily Political
Midatech Pharma plc (NASDAQ:MTP) gapped up before the market opened on Monday . The stock had previously closed at $2.00, but opened at $2.78. Midatech Pharma shares last traded at $2.60, with a volume of 199,218 shares. The stock has a 50 day moving average price of $1.92 and a 200 day moving average price […]
   MOVERS OF MONDAY 19 OCTOBER 2020 - Vox Markets  2020/10/19 15:53:35 VOX Markets
See Today's Market Movers Featuring Cineworld, Bezant Resources, Remote Monitored Systems, Midatech Pharma and FirstGroup
   Midatech Pharma (NASDAQ:MTP) Shares Gap Up to $2.00  2020/10/21 01:18:51 Daily Political
Midatech Pharma plc (NASDAQ:MTP) gapped up before the market opened on Monday . The stock had previously closed at $2.00, but opened at $2.78. Midatech Pharma shares last traded at $2.60, with a volume of 199,218 shares. The stock has a 50 day moving average price of $1.92 and a 200 day moving average price […]
   MOVERS OF MONDAY 19 OCTOBER 2020 - Vox Markets  2020/10/19 15:53:35 VOX Markets
See Today's Market Movers Featuring Cineworld, Bezant Resources, Remote Monitored Systems, Midatech Pharma and FirstGroup
   Midatech Pharma MTX110 could double rare brain tumour survival beyond a year - UK Investor Magazine  2020/10/19 12:56:15 UK Investor Magazine
Midatech Pharma said that median survival based on Kaplan Meier analysis was 26.06 months, with survival beyond 12 months more than doubling, to 71.4%…
   Midatech Pharma PLC Second Price Monitoring Extn  2020/10/19 10:06:00 ADVFN UK
Midatech Pharma PLC 19 October 2020 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated…
   Midatech Pharma PLC Price Monitoring Extension  2020/10/19 10:00:00 ADVFN UK
Midatech Pharma PLC 19 October 2020 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes…

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 マイダテック・ファ―マ MTP Midatech Pharma PLC)

 twitter  (公式ツイッターやCEOツイッターなど)